Stockscreener 앱 받기
0.6752
2.82%
-0.0196
Kala Bio Inc 주식(KALA)의 최신 뉴스
Top Penny Stocks To ResearchDecember 4th - MarketBeat
What drives KALA BIO Inc stock priceSmall Cap Stock Opportunities & Low Risk Wealth Plans - earlytimes.in
You might want to take a look at Kala Bio Inc (KALA) now - setenews.com
Kala Bio enters securities purchase agreement with David Lazar, names him CEO - MSN
Kala Bio Shares Jump After $6 Million Funding Deal With Investor David Lazar - MSN
KALA BIO Raises $10M in Direct Offering - TipRanks
KALA BIO closes $10 million registered direct offering - Investing.com India
KALA BIO Raises $10 Million From Direct Offering - marketscreener.com
KALA BIO closes $10 million registered direct offering By Investing.com - Investing.com South Africa
KALA BIO Announces Closing of $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules - The Manila Times
KALA BIO (NASDAQ: KALA) completes $10 million offering of 10,000,000 shares to repay debt - Stock Titan
Will KALA BIO Inc. stock continue upward momentumMarket Risk Summary & Community Consensus Picks - Newser
Kala Bio raises $10 million in registered direct offering By Investing.com - Investing.com Nigeria
KALA BIO Stock (NASDAQ: KALA): New $10 Million Offering, Debt Deal and Delisting Risk – December 4, 2025 Update - ts2.tech
KALA BIO, Inc. (KALA) Stock: Surges 21.62% Amid Exciting New Offering Announcement - parameter.io
KALA Bio (KALA) Announces $10 Million Direct Stock Offering - GuruFocus
KALA BIO (KALA) Stock Explodes on Oxford Deal and $10M Offering: What December 4, 2025 Means for Investors - ts2.tech
Kala Bio announces $10 mln registered direct offering of common stock - marketscreener.com
Kala Bio Reports $10 Million Direct Stock Offering; Shares Rise - marketscreener.com
Kala Bio raises $10 million in registered direct offering - Investing.com
KALA BIO Announces $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules - The Manila Times
KALA BIO Announces $10 Million Registered Direct Offering - GlobeNewswire
KALA BIO (NASDAQ: KALA) prices $10M registered direct sale of 10M shares at $1.00 - Stock Titan
KALA Bio’s Bold Move: A New Dawn? - timothysykes.com
Aug Mood: Will KALA BIO Inc stock continue upward momentumTrade Analysis Report & AI Driven Stock Price Forecasts - BỘ NỘI VỤ
Why Did KALA BIO Shares Jump Over 22% After Hours? - Benzinga
Will KALA BIO Inc. stock split attract more investors2025 Analyst Calls & Detailed Earnings Play Strategies - Newser
KALA BIO, Inc. (KALA) -10.9% in Intraday Trading: Shares Decline Amid Routine Activity - Stocks Telegraph
Is KALA BIO Inc. stock a buy before product launchesJuly 2025 Intraday Action & Daily Stock Trend Reports - Newser
No data: Challenges Affecting KALA Stock Movements - StocksToTrade
An analyst sees good growth prospects for Kala Bio Inc (KALA) - Setenews
KALA BIO's $6M Leadership Turnaround Boosts Shares - Mena FN
KALA BIO Inc. (KALA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Kala Bio secures $6 million investment as CEO changes amid trial failure By Investing.com - Investing.com Australia
KALA Stock Soars: Buying Opportunity? - StocksToTrade
KALA BIO, Inc. (KALA) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Crude Oil Gains Over 1%; ISM Manufacturing PMI Falls In November - Benzinga
Dow Dips 200 Points; Q32 Bio Shares Jump - Benzinga
Kala Bio stock soars after $6M investment from David Lazar By Investing.com - Investing.com Nigeria
KALA’s Unexpected Surge: Unpacking the Recent Spike - timothysykes.com
Kala Bio enters into $6 million securities purchase agreement with investor David E. Lazar - marketscreener.com
KALA Secures $6M Investment, Appoints New CEO - GuruFocus
KALA BIO Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar - The Manila Times
KALA BIO, Inc. Announces $6 Million Securities Purchase Agreement and Appointment of David E. Lazar as CEO - Quiver Quantitative
KALA BIO (NASDAQ: KALA) inks $6M securities deal, appoints David Lazar CEO and chair - Stock Titan
KALA BIO plunges 92% after phase 2 failure of eye condition drug - MSN
Is Kala Bio Inc (KALA) positioned for future growth? - Setenews
1.08%
0.91%
자본화:
|
볼륨(24시간):